STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.
Fauvre A, Machu M, Merienne A, Vie N, Bessede T, Robin M, Garambois V, Taffoni C, Laguette N, Gervois-Segain N, Jarry A, Labarriere N, Allory Y, Larbouret C, Gros L, Tosi D, Solit DB, Pourquier P, Houédé N, Gongora C.
Fauvre A, et al. Among authors: machu m.
Clin Transl Med. 2024 Sep;14(9):e70011. doi: 10.1002/ctm2.70011.
Clin Transl Med. 2024.
PMID: 39269751
Free PMC article.
No abstract available.